Skip to main content

Advertisement

Log in

Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The neutrophil-to-lymphocyte ratio (NLR) has been reported to predict the prognosis of various malignant tumors, including esophageal cancer. However, no previous reports have supported the use of the preoperative NLR as an independent prognostic marker focused on superficial (T1) esophageal cancer. The aim of this study was to elucidate the prognostic impact of the preoperative NLR in T1 esophageal cancer.

Methods

This retrospective study recruited 245 consecutive patients with T1 esophageal cancer who underwent subtotal esophagectomy between 2005 and 2016. The relationship between the preoperative NLR and clinicopathological characteristics was analyzed.

Results

The preoperative NLR was significantly higher in male patients (p = 0.029), patients with T1b esophageal cancer (p = 0.0274), and patients with venous vessel invasion (p = 0.0082). In the Kaplan–Meier analysis, the elevated preoperative NLR was significantly associated with a poorer disease-free survival (p < 0.0001) and overall survival (p = 0.0004). In the multivariate Cox model, the elevated preoperative NLR was an independent prognostic marker for both disease-free survival (p = 0.0013) and overall survival (p = 0.0027).

Conclusion

An elevated preoperative NLR predicts poor prognosis in T1 esophageal cancer, suggesting the utility of the NLR as an easily measurable and generally available independent prognostic marker.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349(23):2241–2252

    Article  CAS  PubMed  Google Scholar 

  2. Allum WH, Stenning SP, Bancewicz J et al (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27(30):5062–5067

    Article  PubMed  Google Scholar 

  3. Rizk NP, Ishwaran H, Rice TW et al (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251(1):46–50

    Article  PubMed  Google Scholar 

  4. Thallinger CM, Raderer M, Hejna M (2011) Esophageal cancer: a critical evaluation of systemic second-line therapy. J Clin Oncol 29(35):4709–4714

    Article  CAS  PubMed  Google Scholar 

  5. Dubecz A, Kern M, Solymosi N et al (2015) Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg 99(6):1879–1885 (discussion 1886)

    Article  PubMed  Google Scholar 

  6. Baba Y, Murata A, Watanabe M et al (2014) Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer. Surg Today 44(10):1807–1816

    Article  CAS  PubMed  Google Scholar 

  7. Morita M, Otsu H, Kawano H et al (2014) Gender differences in prognosis after esophagectomy for esophageal cancer. Surg Today 44(3):505–512

    Article  PubMed  Google Scholar 

  8. Nakamura M, Iwahashi M, Nakamori M et al (2014) New prognostic score for the survival of patients with esophageal squamous cell carcinoma. Surg Today 44(5):875–883

    Article  CAS  PubMed  Google Scholar 

  9. Arima K, Okabe H, Hashimoto D et al (2016) The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases. Int J Clin Oncol 21(5):940–945

  10. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545

    Article  CAS  PubMed  Google Scholar 

  11. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Proctor MJ, Morrison DS, Talwar D et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47(17):2633–2641

    Article  PubMed  Google Scholar 

  13. Proctor MJ, Talwar D, Balmar SM et al (2010) The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer 103(6):870–876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gomez D, Morris-Stiff G, Toogood GJ et al (2008) Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 97(6):513–518

    Article  PubMed  Google Scholar 

  15. Zahorec R (2001) Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5–14

    CAS  PubMed  Google Scholar 

  16. Paramanathan A, Saxena A, Morris DL (2014) A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 23(1):31–39

    Article  PubMed  Google Scholar 

  17. Mano Y, Shirabe K, Yamashita Y et al (2013) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 258(2):301–305

    Article  PubMed  Google Scholar 

  18. Kishi Y, Kopetz S, Chun YS et al (2009) Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16(3):614–622

    Article  PubMed  Google Scholar 

  19. Sugiura T, Uesaka K, Kanemoto H et al (2013) Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma. Ann Surg Oncol 20(13):4330–4337

    Article  PubMed  Google Scholar 

  20. Zhang X, Zhang W, Feng LJ (2014) Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. PLoS ONE 9(11):e111906

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kosumi K, Baba Y, Ishimoto T et al (2016) Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients. Surg Today 46(4):405–413

    Article  CAS  PubMed  Google Scholar 

  22. Sharaiha RZ, Halazun KJ, Mirza F et al (2011) Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 18(12):3362–3369

    Article  PubMed  PubMed Central  Google Scholar 

  23. Shimada H, Takiguchi N, Kainuma O et al (2010) High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13(3):170–176

    Article  PubMed  Google Scholar 

  24. Rice TW, Blackstone EH, Rusch VW (2010) 7th edition of the AJCC cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol 17(7):1721–1724

    Article  PubMed  Google Scholar 

  25. McShane LM, Altman DG, Sauerbrei W et al (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97(16):1180–1184

    Article  CAS  PubMed  Google Scholar 

  26. Kodama M, Kakegawa T (1998) Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123(4):432–439

    Article  CAS  PubMed  Google Scholar 

  27. Tanaka T, Matono S, Mori N et al (2014) T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy. Ann Surg Oncol 21(3):932–938

    Article  PubMed  Google Scholar 

  28. Schmidt H, Suciu S, Punt CJ et al (2007) Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol 25(12):1562–1569

    Article  CAS  PubMed  Google Scholar 

  29. Donskov F, Bennedsgaard KM, Hokland M et al (2004) Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma. Cancer Immunol Immunother 53(8):729–739

    Article  CAS  PubMed  Google Scholar 

  30. Teramukai S, Kitano T, Kishida Y et al (2009) Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 45(11):1950–1958

    Article  PubMed  Google Scholar 

  31. Riesco A (1970) Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 25(1):135–140

    Article  CAS  PubMed  Google Scholar 

  32. Atzpodien J, Royston P, Wandert T et al (2003) Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 88(3):348–353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Negrier S, Escudier B, Gomez F et al (2002) Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d’Immunotherapie. Ann Oncol 13(9):1460–1468

    Article  CAS  PubMed  Google Scholar 

  34. Kitayama J, Yasuda K, Kawai K et al (2010) Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol 5:47

    Article  PubMed  PubMed Central  Google Scholar 

  35. Clark EJ, Connor S, Taylor MA et al (2007) Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) 9(6):456–460

    Article  CAS  Google Scholar 

  36. Suzuki S, Toyabe S, Moroda T et al (1997) Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 110(3):500–508

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wang S, Zhang Z, Fang F et al (2011) The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2(4):735–740

    PubMed  PubMed Central  Google Scholar 

  38. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883–899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Webb NJ, Myers CR, Watson CJ et al (1998) Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 10(4):254–257

    Article  CAS  PubMed  Google Scholar 

  40. Jablonska E, Puzewska W, Grabowska Z et al (2005) VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine 30(3):93–99

    Article  CAS  PubMed  Google Scholar 

  41. Ardi VC, Kupriyanova TA, Deryugina EI et al (2007) Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci USA 104(51):20262–20267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Petrie HT, Klassen LW, Kay HD (1985) Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134(1):230–234

    CAS  PubMed  Google Scholar 

  43. el-Hag A, Clark RA (1987) Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 139(7):2406–2413

    CAS  PubMed  Google Scholar 

  44. Shau HY, Kim A (1988) Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141(12):4395–4402

    CAS  PubMed  Google Scholar 

  45. Kay HD, Smith DL (1983) Regulation of human lymphocyte-mediated natural killer (NK) cell activity. I. Inhibition in vitro by peripheral blood granulocytes. J Immunol 130(1):475–483

    CAS  PubMed  Google Scholar 

  46. McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226

    Article  PubMed  Google Scholar 

  47. Dou X, Wang RB, Yan HJ et al (2013) Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases. Asian Pac J Cancer Prev 14(6):3881–3885

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideo Baba.

Ethics declarations

Conflict of interest

No conflicts of interest exist.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, K., Yoshida, N., Baba, Y. et al. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer. Int J Clin Oncol 22, 469–475 (2017). https://doi.org/10.1007/s10147-017-1090-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-017-1090-5

Keywords

Navigation